40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
9.25B
Better than VET's estimated revenue of 1.86B.
1.85B
Better than VET's estimated ebitda of 842.68M.
5.37
Better than VET's estimated eps of 0.30.
1.42B
Better than VET's estimated net income of 49.93M.
-27.91M
Worse than VET's estimated ebit of 235.12M.
1.60B
Worse than VET's estimated sg&a expense of 148.80M.
Analyze DCF forecasts for the company and compare them with competitors.
6.09B
Better than VET's revenue of 863.55M.
-9.50%
Better than VET's revenue growth rate of -34.73%.
-3.50B
Worse than VET's ebitda of 271.53M.
-57.43%
Worse than VET's ebitda margin of 31.44%.
-5.36B
Worse than VET's ebit of -154.76M.
-88.04%
Worse than VET's ebit margin of -17.92%.
1.86B
Worse than VET's depreciation of 426.29M.
10.00M
Better than VET's total cash of 4.78M.
0.16%
Worse than VET's cash as percentage of revenue of 0.55%.
867.00M
Worse than VET's receivables of 135.74M.
14.24%
Better than VET's receivables as percentage of revenue of 15.72%.
23.00M
Worse than VET's inventories of 9.28M.
0.38%
Better than VET's inventories as percentage of revenue of 1.07%.
306.00M
Worse than VET's accounts payable of 187.09M.
5.03%
Better than VET's payables as percentage of revenue of 21.67%.
-1.74B
Better than VET's capital expenditure of -254.21M.
-28.52%
Worse than VET's capex as percentage of revenue of -29.44%.
12.25%
Better than VET's weighted average cost of capital (wacc) of 13.62%.
16.87%
Worse than VET's cost of equity of 16.56%.
5.31%
Better than VET's cost of debt of 9.00%.
2.64
Worse than VET's beta of 2.58.
263.90M
Worse than VET's diluted shares outstanding of 163.72M.
6.68B
Worse than VET's total debt of 655.60M.
10.03B
Better than VET's total equity of 1.42B.
16.71B
Better than VET's total capital of 2.07B.
39.98%
Worse than VET's debt weighting of 31.64%.
60.02%
Worse than VET's equity weighting of 68.36%.
-5.70B
Worse than VET's ebiat of -125.09M.
-5.35B
Worse than VET's unlevered free cash flow of 84.50M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-12.22B
Worse than VET's terminal value of 5.64B.
-10.85B
Worse than VET's enterprise value of 4.50B.
6.68B
Worse than VET's net debt of 557.67M.
-17.53B
Worse than VET's equity value of 3.94B.
-66.42
Worse than VET's equity value per share of 24.07.
